Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pharmacogenomics Cytochrome

Guengerich, F.P., "Pharmacogenomics of Cytochrome P450 and Other Enzymes Involved in Biotransformation of Xenobiotics," Drug Devel. Res., 49, 4-16 (2000). [Pg.225]

Ingelman-Sundberg, M. (2005) Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics Journal, 5 (1), 6-13. [Pg.235]

Pai HV, Upadhya SC, Chinta SJ, Hegde SN, Ravindranath V. 2002. Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite. Pharmacogenomics J 2 243-258. [Pg.88]

Sikka R, Magauran B, Ulrich A, Shannon M. Bench to bedside pharmacogenomics, adverse drug interactions, and the cytochrome P450 system. Acad Emerg Med 2005 12(12) 1227-35. [Pg.262]

Evans, W.E. and Relling, M.V. (1999) Pharmacogenomics translating functional genomics into rational therapeutics. Science, 286, 487—4-91. Wijnen, P.A. et cd. (2007) Review article. The prevalence and clinical relevance of cytochrome P450 polymorphisms. Aliment. Pharmacol. Then, 26 (Suppl 2), 211-219. [Pg.72]

Lewis DF. 57 varieties the human cytochromes P450. Pharmacogenomics. 2004 5 305-318. [Pg.38]

Serrano D et al (2011) Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian tamoxifen prevention trial. Pharmacogenomics J 11 100-107... [Pg.247]

Pickering JW, McMillin GA, Gedge F> Hill HR, Lyon E. Flow cytometric assay for genotyping cytochrome p450 2C9 and 2C19 comparison with a microelectronic DNA array. Am J Pharmacogenomics 2004 4 199-207. [Pg.1615]

Leskela S, Jara C, Leandro-Garcia LJ et al (2011) Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity. Pharmacogenomics J 11 121-129... [Pg.322]

Fleeman N, Dundar Y, Dickson R, Jorgensen A, Pushpakom S, McLeod C et al (2011) Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia systematic review and meta-analyses. Pharmacogenomics J 11 1-14... [Pg.585]

Gomez A, Ingelman-Sundberg M (2009) Epigenetic and microRNA-dependent control of cytochrome P 450 expression a gap betweenDNAandprotein. Pharmacogenomics 10 1067-1076... [Pg.684]

Brockmoller J, Kirchheiner J, Meisel C, etal. Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment. Pharmacogenomics 2000 1 125-151. [Pg.280]

See other pages where Pharmacogenomics Cytochrome is mentioned: [Pg.218]    [Pg.379]    [Pg.85]    [Pg.210]    [Pg.290]    [Pg.210]    [Pg.64]    [Pg.213]    [Pg.214]    [Pg.518]    [Pg.527]    [Pg.531]    [Pg.37]    [Pg.432]    [Pg.316]    [Pg.128]    [Pg.275]    [Pg.286]    [Pg.739]    [Pg.483]    [Pg.551]    [Pg.673]    [Pg.129]    [Pg.326]    [Pg.333]    [Pg.477]    [Pg.203]    [Pg.90]   
See also in sourсe #XX -- [ Pg.268 ]



SEARCH



Pharmacogenomic

Pharmacogenomics

© 2024 chempedia.info